Five-year survivors with resected PN2 nonsmall cell lung carcinoma
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference19 articles.
1. Mediastinal Nodal Involvement and the Prognosis of Non-Small Cell Lung Cancer
2. Factors determining survival in resected N2 lung cancer
3. Results of resection for bronchogenic carcinoma with mediastinal lymph node metastases in selected patients
4. Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. スキップN2(#3a)転移と思われた混合型大細胞神経内分泌癌の一例;The Journal of the Japanese Association for Chest Surgery;2023-11-15
2. The Impact of Skip vs. Non-Skip N2 Lymph Node Metastasis on the Prognosis of Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis;Frontiers in Surgery;2021-10-12
3. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients;European Journal of Surgical Oncology;2020-10
4. Role of Skip Mediastinal Lymph Node Metastasis for Patients With Resectable Non–small-cell Lung Cancer: A Propensity Score Matching Analysis;Clinical Lung Cancer;2019-05
5. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease);Interactive CardioVascular and Thoracic Surgery;2018-07-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3